Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical OncologyC Grávalos, O Sanmartín, A Gúrpide, et al.
ESMO Open|February 24, 2024
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)A M Di Giacomo, M Schenker, J Medioni, et al.
Investigational New Drugs|January 5, 2012
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumorsC Massard, R Salazar, J P Armand, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Risk of malnutrition and emotional distress as factors affecting health-related quality of life in patients with resected cancerC Calderon, A Carmona-Bayonas, C Beato, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Lung cancer in women: an overview with special focus on Spanish womenJ Remon, E Molina-Montes, M Majem, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2017
KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancerI Sullivan, J Salazar, C Arqueros, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2019
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancerM Majem, J Hernández-Hernández, F Hernando-Trancho, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines on nutrition in cancer patients (2018)R de Las Peñas, M Majem, J Perez-Altozano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 17, 2019
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU programJ Corral, M Majem, D Rodríguez-Abreu, et al.
Pageof 4